Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global Industry Assessment & Forecast
#
Pages:
250
Base Year:
2023
Oct - 2024
Format:
Report Code:
VMR-2688
Segments Covered
By
Drug Class Bronchodilators, Phosphodiesterase Type 4 Inhibitors, Corticosteroids, Others
-
By
Route of Administration Oral, Inhalation
-
By
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 18.2 Billion |
 Revenue 2032:
|
USD 28.4 Billion |
 Revenue CAGR
(2024 - 2032): |
4.9% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Segment Analysis
- Chronic Obstructive Pulmonary Disease (COPD) Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Chronic Obstructive Pulmonary Disease (COPD) Treatment Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Inhalation
- Chronic Obstructive Pulmonary Disease (COPD) Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
-
North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
-
North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S.
- U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.S. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Canada
- Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Mexico
- Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Europe
-
Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
-
Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
-
Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U. K.
- U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- France
- France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Germany
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Italy
- Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Spain
- Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Spain Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Rest of Europe
- Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Asia Pacific
-
Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
-
Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
-
Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China
- China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Japan
- Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Germany
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
India
- India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
South Korea
- South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
South East Asia
- South East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- South East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- South East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South East Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Rest of Asia Pacific
- Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Latin America
-
Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
-
Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
-
Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil
- Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Argentina
- Argentina Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Argentina Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Argentina Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Argentina Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Rest of Latin America
- Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Middle East & Africa
-
Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
-
Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
-
Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries
- GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GCC Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- South Africa
- South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- Bronchodilators
- Phosphodiesterase Type 4 Inhibitors
- Corticosteroids
- Others
- Rest of Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Route of Administration
- Oral
- Inhalation
- Rest of Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rest of Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
-
Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, by Drug Class
- North America
Vantage Market
Research | 16-Oct-2024
FAQ
Frequently Asked Question
What is the global demand for Chronic Obstructive Pulmonary Disease (COPD) Treatment in terms of revenue?
-
The global Chronic Obstructive Pulmonary Disease (COPD) Treatment valued at USD 18.2 Billion in 2023 and is expected to reach USD 28.4 Billion in 2032 growing at a CAGR of 4.9%.
Which are the prominent players in the market?
-
The prominent players in the market are Astrazeneca, Alkem, Mylan N.V., Novartis AG, F.Hoffman-La Roche Ltd, Genentech Inc, Theravance Biopharma, Sunovion Pharmacuticals Inc, Sanofi, Verona Pharmaceuticals.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.9% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Chronic Obstructive Pulmonary Disease (COPD) Treatment include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Chronic Obstructive Pulmonary Disease (COPD) Treatment in 2023.
